Healthcare >> Analyst Interviews >> March 18, 2002
TWST: It's been a year or so since we spoke for the last JOHN D. RHODES, CPA, is Deloitte & Touche's Managing Partner for
Pharmaceuticals and Life Sciences. In this role, he is
responsible for the firm's services to pharmaceutical,
biotechnology and medical technology and device companies. Mr.
Rhodes has significant experience with pharmaceutical,
manufacturing and process industries, focusing on accounting and
auditing, SEC reporting, business process and contracting issues,
corporate compliance, strategic alliances, research and promotion
collaborations, joint venture formations and mergers and
acquisitions. He has published in Pharmaceutical Executive and
has co-authored firm publications on the Life Sciences industry.
He is a member of the firm's Manufacturing Industry Operating
conference issue. What has gone on in the pharmaceutical industry
over that period of time that people should know about?